| For: | Rungsakulkij N, Suragul W, Mingphruedhi S, Tangtawee P, Muangkaew P, Aeesoa S. Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection. World J Clin Cases 2018; 6(6): 110-120 [PMID: 29988930 DOI: 10.12998/wjcc.v6.i6.110] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v6/i6/110.htm |
| Number | Citing Articles |
| 1 |
Fuqiang Zhang, Lin Zheng, Deyu Li, Hui Yang. To explore the curative effect of CT-guided Iodine-125 radioactive seed implantation in the treatment of stage Ⅳprimary hepatocellular carcinoma. Journal of Interventional Medicine 2021; 4(2) doi: 10.1016/j.jimed.2021.02.009
|
| 2 |
Lei Liang, Ming-Da Wang, Yao-Ming Zhang, Wan-Guang Zhang, Cheng-Wu Zhang, Wan Yee Lau, Feng Shen, Timothy M Pawlik, Dong-Sheng Huang, Tian Yang. Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml). Journal of Hepatocellular Carcinoma 2021; doi: 10.2147/JHC.S289840
|
| 3 |
Hongyi Yang, Linbin Lu, Wanting Guo, Baocuo Gong, Xuewen Wang, Yaying Chen, Xiong Chen. A Longitudinal Study of AFP Trajectories and Clinical Outcomes in Intermediate-Stage Hepatocellular Carcinoma After Hepatectomy. Journal of Hepatocellular Carcinoma 2024; doi: 10.2147/JHC.S432011
|
| 4 |
Arjan Deol, Jonathan Lindquist, Katherine Marchak, J.P. Norvell, Leigh Casadaban. Striking elevation of alpha-fetoprotein during acute transient myopathy following Yttrium-90 transarterial radioembolization. Journal of Hepatology 2026; 84(1) doi: 10.1016/j.jhep.2025.09.031
|
| 5 |
Nobuharu Tamaki, Toshifumi Tada, Masayuki Kurosaki, Yutaka Yasui, Hironori Ochi, Toshie Mashiba, Azusa Sakamoto, Hiroyuki Marusawa, Ryoichi Narita, Yasushi Uchida, Takehiro Akahane, Masahiko Kondo, Nami Mori, Shintaro Takaki, Keiji Tsuji, Haruhiko Kobashi, Atsunori Kusakabe, Koichiro Furuta, Hirotaka Arai, Michiko Nonogi, Chikara Ogawa, Takashi Sato, Takashi Tamada, Shinichiro Nakamura, Chitomi Hasebe, Kaoru Tsuchiya, Namiki Izumi. Optimal threshold of alpha-fetoprotein response in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab. Investigational New Drugs 2022; 40(6) doi: 10.1007/s10637-022-01303-w
|
| 6 |
Linbin Lu, Lujun Shen, Zhixian Wu, Yanhong Shi, Peifeng Hou, Zengfu Xue, Cheng Lin, Xiong Chen. Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study. eClinicalMedicine 2022; 47 doi: 10.1016/j.eclinm.2022.101391
|
| 7 |
Bo Liu, Xiao Shang, Jin-Yu Shi, Guo-Zhen Cui, Xi Li, Nan-Ya Wang. Early Alpha-Fetoprotein Response Is Associated With Survival in Patients With HBV-Related Hepatocellular Carcinoma Receiving Lenvatinib. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.807189
|
| 8 |
Lea Penzkofer, Jens Mittler, Stefan Heinrich, Nicolas Wachter, Beate Straub, Roman Kloeckner, Fabian Stoehr, Simon Gairing, Fabian Bartsch, Hauke Lang. Outcome after Resection for Hepatocellular Carcinoma in Noncirrhotic Liver—A Single Centre Study. Journal of Clinical Medicine 2022; 11(19) doi: 10.3390/jcm11195802
|
| 9 |
Neal Bhutiani, Stephen J. O'Brien, Erin E. Priddy, Michael E. Egger, Young K. Hong, Megan K. Mercer, Kelly M. McMasters, Robert C.G. Martin, Melissa H. Potts, Charles R. Scoggins. Correlating serum alpha-fetoprotein in hepatocellular carcinoma with response to Yttrium-90 transarterial radioembolization with glass microspheres (TheraSphere™). HPB 2020; 22(9) doi: 10.1016/j.hpb.2019.12.007
|
| 10 |
Xiu-Ping Zhang, Zhen-Hua Chen, Teng-Fei Zhou, Le-Qun Li, Min-Shan Chen, Tian-Fu Wen, Jie Shi, Wei-Xing Guo, Meng-Chao Wu, Wan Yee Lau, Shu-Qun Cheng. A nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection: A large-scale, multicenter study. European Journal of Surgical Oncology 2019; 45(9) doi: 10.1016/j.ejso.2019.03.043
|
| 11 |
Qing Zhang, Yun-Er Tian, Dong-Feng Wu, Wei-Xiong Zhu, Shuang Qiu, Ning Jiao, Qun-Wei Yu, Lei Shang, Jia-Jia He. High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation. World Journal of Gastrointestinal Oncology 2021; 13(7): 716-731 doi: 10.4251/wjgo.v13.i7.716
|
| 12 |
Li-Yue Sun, Wen-Jian Cen, Wen-Ting Tang, Ling Deng, Fang Wang, Xiao-Meng Ji, Jiao-Jiao Yang, Ren-Jing Zhang, Xu-Hui Zhang, Zi-Ming Du, Jie Mei. Alpha-Fetoprotein Ratio Predicts Alpha-Fetoprotein Positive Hepatocellular Cancer Patient Prognosis after Hepatectomy. Disease Markers 2022; 2022 doi: 10.1155/2022/7640560
|
| 13 |
Yang-Xun Pan, Xu-Qi Sun, Zi-Li Hu, Wa Xie, Ke-Xin Nie, Ai-Ping Fang, Ying-Yao Zhang, Yi-Zhen Fu, Jin-Bin Chen, Jun-Cheng Wang, Xin Wang, Yao-Jun Zhang, Dan-Dan Hu, Min-Shan Chen. Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients. Journal of Hepatocellular Carcinoma 2021; doi: 10.2147/JHC.S316223
|
| 14 |
Mengling Ji, Hao Zou, Baojun Shu, Guoping Liu, Bingyuan Zhang, Zejiang Xu, Fanfan Pang, Mengxing Cheng, Yafei Sun, Ting Du, Chuandong Sun, Chengzhan Zhu. Prognostic analysis of hepatocellular carcinoma with macrovascular invasion after liver resection and a successful case of conversion therapy. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.1042431
|
| 15 |
Peng-Ji Pan, Jun-Xia Liu. Diagnostic and prognostic value of secreted protein acidic and rich in cysteine in the diffuse large B-cell lymphoma. World Journal of Clinical Cases 2021; 9(22): 6287-6299 doi: 10.12998/wjcc.v9.i22.6287
|
| 16 |
Dong-Hoon Lim, Andrea Casadei-Gardini, Myung Ah Lee, Sara Lonardi, Jin Won Kim, Gianluca Masi, Hong Jae Chon, Margherita Rimini, Ilhwan Kim, Jaekyung Cheon, Jun-Eul Hwang, Jung Hun Kang, Ho Yeong Lim, Changhoon Yoo. Prognostic Implication of Serum AFP in Patients with Hepatocellular Carcinoma Treated with Regorafenib. Future Oncology 2022; 18(27) doi: 10.2217/fon-2022-0524
|
| 17 |
Yitao Zheng, Jingna Hu, Yingna Mei, Yanjun Xiang, Haofeng Lu, Jiuting Zhu, Kaile Pan, Shuqun Cheng, Yang Liu. Trajectories of α-fetoprotein and unresectable hepatocellular carcinoma outcomes receiving lenvatinib: a retrospective, multicenter cohort study. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-14516-y
|
| 18 |
Rong-yun Mai, Jie Zeng, Wei-da Meng, Hua-ze Lu, Rong Liang, Yan Lin, Guo-bin Wu, Le-qun Li, Liang Ma, Jia-zhou Ye, Tao Bai. Artificial neural network model to predict post-hepatectomy early recurrence of hepatocellular carcinoma without macroscopic vascular invasion. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-07969-4
|
| 19 |
Anand Bharathan, V. Sitaram. GI Surgery Annual. GI Surgery Annual 2019; 25 doi: 10.1007/978-981-13-3227-2_5
|
| 20 |
Mingda Wang, Guojun Qian, Hongmei Xiao, Xingkai Liu, Liyang Sun, Zhong Chen, Kongying Lin, Lanqing Yao, Chao Li, Lihui Gu, Jiahao Xu, Xiaodong Sun, Wei Qiu, Timothy M Pawlik, Wan Yee Lau, Guoyue Lv, Feng Shen, Tian Yang. Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patients. The Oncologist 2024; 29(12) doi: 10.1093/oncolo/oyae139
|
| 21 |
Jendrik Becker-Assmann, Mohammad H. Fard-Aghaie, Alexandros Kantas, Georgios Makridis, Tim Reese, Kim C. Wagner, Jörg Petersen, Peter Buggisch, Axel Stang, Thomas von Hahn, Karl J. Oldhafer. Diagnostische und prognostische Bedeutung des α-Feto-Proteins beim hepatozellulären Karzinom. Der Chirurg 2020; 91(9) doi: 10.1007/s00104-020-01118-6
|
| 22 |
Ashokachakkaravarthy Kandasamy, Biju Pottakkat. Alpha-fetoprotein: A molecular bootstrap for hepatocellular carcinoma. International Journal of Molecular and Immuno Oncology 2020; 5 doi: 10.25259/IJMIO_5_2020
|
| 23 |
Yu-Liang Huang, Jun-Rong Wu, Min Fang, Hui-Liu Zhao, Zhi-Min Liu, Jian Ye, Ling-Sha Huang, Bo Zhu. The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma. Medicine 2019; 98(14) doi: 10.1097/MD.0000000000015090
|
| 24 |
Jia-Jia He, Lei Shang, Qun-Wei Yu, Ning Jiao, Shuang Qiu, Wei-Xiong Zhu, Dong-Feng Wu, Yun-Er Tian, Qing Zhang. High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation. World Journal of Gastrointestinal Oncology 2021; 13(7) doi: 10.4251/wjgo.v13.i7.541
|
| 25 |
Rabia Ashiq, Batool Fatima, Mohibullah Shah, Dilshad Hussain, Abrar Mohyuddin, Saadat Majeed, Rubaida Mehmood, Muhammad Imran, Muhammad Naeem Ashiq, Muhammad Najam-ul-Haq. Tin derived antimony/nitrogen-doped porous carbon (Sb/NPC) composite for electrochemical sensing of albumin from hepatocellular carcinoma patients. Microchimica Acta 2021; 188(10) doi: 10.1007/s00604-021-05005-7
|
| 26 |
Gang Hou, Bo Liu, Zhong-Qi Fan, Chao Li, Jian-Ping Zhang, Yan-Hui Guo, Ru-Yi Zhang, Yi Zheng, Hong Zhu, Nan-Ya Wang. Association between early response of alpha-fetoprotein and treatment efficacy of systemic therapy for advanced hepatocellular carcinoma: A multicenter cohort study from China. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1094104
|
| 27 |
Chao He, Wei Peng, Xiaojuan Liu, Chuan Li, Xueting Li, Tian-Fu Wen. Post-treatment alpha-fetoprotein response predicts prognosis of patients with hepatocellular carcinoma. Medicine 2019; 98(31) doi: 10.1097/MD.0000000000016557
|
| 28 |
Qi Zhao, Yiqiu Xu, Dandan Yuan, Junjun Yang, Ying Wang, Guorong Shen, Xuewen Huang, Nashwa El-Khazragy. Role of ssDNA as a Noninvasive Indicator for the Diagnosis and Prognosis of Hepatocellular Carcinoma: An Exploratory Study. Disease Markers 2021; 2021 doi: 10.1155/2021/9958909
|
| 29 |
Robin Kate Kelley, Tim Meyer, Lorenza Rimassa, Philippe Merle, Joong-Won Park, Thomas Yau, Stephen L. Chan, Jean-Frederic Blanc, Vincent C. Tam, Albert Tran, Vincenzo Dadduzio, David W. Markby, Rajesh Kaldate, Ann-Lii Cheng, Anthony B. El-Khoueiry, Ghassan K. Abou-Alfa. Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma. Clinical Cancer Research 2020; 26(18) doi: 10.1158/1078-0432.CCR-19-3884
|
| 30 |
Li-Yue Sun, Wen-Jian Cen, Xin-Xin Zeng, Yu-Yun Zhong, Ling Deng, Jiao-Jiao Yang, Ming Li, Fang Wang. The Prognostic Value of Alpha-Fetoprotein Ratio in Patients With Resectable Alpha-Fetoprotein-Negative Hepatocellular Carcinoma. The American Surgeon™ 2024; 90(6) doi: 10.1177/00031348241227202
|
| 31 |
Xiaojun Hu, Changfeng Li, Qiang Wang, Xueyun Wu, Zhiyu Chen, Feng Xia, Ping Cai, Leida Zhang, Yingfang Fan, Kuansheng Ma. Development and External Validation of a Radiomics Model Derived from Preoperative Gadoxetic Acid-Enhanced MRI for Predicting Histopathologic Grade of Hepatocellular Carcinoma. Diagnostics 2023; 13(3) doi: 10.3390/diagnostics13030413
|